GlassScriptPhysician profile
Chris P Doerr
NPI 1003990771
$596.87
in general payments reported to CMS, 2019-2025
9 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Psychiatric/Mental Health, Adult (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $27.00 · 2023: $77.97 · 2024: $155 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275 · Education: $62.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.70 |
| Education | $62.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $200.19 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Neurocrine Biosciences, INC. | $160.58 | 2021-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $81.20 | 2023-2025 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.80 | 2022-2025 | Caplyta |
| Acadia Pharmaceuticals INC | $35.31 | 2024 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $33.50 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $16.63 | 2024 | Cobenfy |
| Vanda Pharmaceuticals INC. | $15.68 | 2024 | Fanapt |
| Indivior INC. | $14.98 | 2023 | Perseris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Doerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.